- Titre
- 3D-QSAR and Docking Studies of Selective GSK-3β Inhibitors. Comparison with a Thieno[2,3-b]pyrrolizinone Derivative, a New Potential Lead for GSK-3β Ligands
- Créateurs - sans rôle
- Elodie Lescot - Cent. Etud. Rech. Med. Normandie, UFR Sci. Pharm., Univ. Caen, F-14032 Caen, FrRonan Bureau - Cent. Etud. Rech. Med. Normandie, UFR Sci. Pharm., Univ. Caen, F-14032 Caen, FrJana Sopkova-de Oliveira Santos - Cent. Etud. Rech. Med. Normandie, UFR Sci. Pharm., Univ. Caen, F-14032 Caen, FrChristophe Rochais - Cent. Etud. Rech. Med. Normandie, UFR Sci. Pharm., Univ. Caen, F-14032 Caen, FrVincent Lisowski - Cent. Etud. Rech. Med. Normandie, UFR Sci. Pharm., Univ. Caen, F-14032 Caen, FrJean-Charles Lancelot - Cent. Etud. Rech. Med. Normandie, UFR Sci. Pharm., Univ. Caen, F-14032 Caen, FrSylvain Rault - Cent. Etud. Rech. Med. Normandie, UFR Sci. Pharm., Univ. Caen, F-14032 Caen, Fr
- Détails de publication
- ChemInform, Vol.36(32), pp.no-no
- Éditeur
- WILEY-VCH Verlag
- Identifiants
- 99138898809311
- Unité académique
- Institut des Biomolécules Max Mousseron - IBMM
- Langue
- English
- Type de ressource
- Journal article
Article de revue
3D-QSAR and Docking Studies of Selective GSK-3β Inhibitors. Comparison with a Thieno[2,3-b]pyrrolizinone Derivative, a New Potential Lead for GSK-3β Ligands
ChemInform, Vol.36(32), pp.no-no
09/08/2005
Indicateurs
1 Consultations de la notice